TD Waterhouse Canada’s Outset Medical OM Stock Holding History

TD Waterhouse Canada’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3	Closed	-$32	–	2070
2025 Q1	$32	Buy	+3	New	+$36	﹤0.01%	1901

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

TD Waterhouse Canada's OM Position: Q2 2025 in Review

TD Waterhouse Canada sold out of Outset Medical (OM) in Q2 2025, closing a stake of 3 shares — an estimated $32 sold.

TD Waterhouse Canada first reported a position in OM in Q1 2025 and held it in 1 quarter. The position peaked at $32 in Q1 2025. 94 funds tracked by Wall St. Rank hold OM as of Q2 2025.

TD Waterhouse Canada reported no remaining Outset Medical position as of Q2 2025 after selling out during the quarter.
TD Waterhouse Canada sold 3 Outset Medical shares in Q2 2025, an estimated $32.
TD Waterhouse Canada first reported a position in Outset Medical in Q1 2025 and held it in 1 quarter.
TD Waterhouse Canada's Outset Medical position peaked at $32 in Q1 2025.
94 funds tracked by Wall St. Rank held Outset Medical as of Q2 2025.

Based on TD Waterhouse Canada's 13F filing for Q2 2025, filed 11 Aug 2025.